SingHealth develops the BiliSG app with Synapxe to detect jaundice in newborns


Share this article

SingHealth and Synapxe develop BiliSG app to detect Jaundice in newborns

Image credit: Lianhe Zaobao

In collaboration with Singapore General Hospital (SGH) and SingHealth Polyclinics (SHP), Synapxe developed an AI-powered smartphone app to enable parents to screen their babies for neonatal jaundice, in the comfort and safety of their homes. Known as BiliSG, the tool captures images with a smartphone camera of the infant's forehead, chest, and abdomen to analyse the skin’s yellowness to accurately predict levels of bilirubin, a yellow pigment resulting from the natural breakdown of red blood cells that causes the yellow tint seen in jaundice.

Andy Ta, Chief Data Officer & Director of Data Analytics & AI, Synapxe said, "We believe that technology, particularly AI, can transform the healthcare industry. Our collaboration with our healthcare partners, such as SGH and SHP, is driven by our shared vision to innovate and enhance healthcare delivery, ultimately improving patient outcomes. While it is currently in the testing phase, the development of the BiliSG© app illustrates how we can leverage AI technologies to assist parents in monitoring their infant's jaundice from the comforts of their homes.”


View the full articles at:

 

Related articles

X

By continuing to use and navigate this website, you consent to the use of cookies in accordance with our Privacy Policy.

Confirm